Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 18,284,000 | 16,701,000 | 15,065,000 | 13,767,000 | 11,984,000 |
| Cost of Goods | 4,856,000 | 4,464,000 | 3,965,000 | 3,637,000 | 3,122,000 |
| Gross Profit | 13,428,000 | 12,237,000 | 11,100,000 | 10,130,000 | 8,862,000 |
| Operating Expenses | 8,307,000 | 7,799,000 | 7,147,000 | 6,515,000 | 5,641,000 |
| Operating Income | 5,121,000 | 4,438,000 | 3,953,000 | 3,615,000 | 3,221,000 |
| Other Income | -853,000 | 44,000 | 60,000 | -1,213,000 | -666,000 |
| Pre-tax Income | 4,268,000 | 4,482,000 | 4,013,000 | 2,402,000 | 2,555,000 |
| Income Tax | 1,127,000 | 1,277,000 | 1,163,000 | 590,000 | 713,000 |
| Net Income Continuous | 3,661,000 | 3,205,000 | 2,850,000 | 2,600,000 | 2,330,446 |
| Net Income | $3,141,000 | $3,205,000 | $2,850,000 | $1,812,000 | $1,842,000 |
| EPS Basic Total Ops | 1.58 | 1.61 | 1.42 | 0.90 | 0.91 |
| EPS Basic Continuous Ops | 1.84 | 1.61 | 1.42 | 1.28 | 1.15 |
| EPS Diluted Total Ops | 1.55 | 1.57 | 1.42 | 0.90 | 0.91 |
| EPS Diluted Continuous Ops | 1.80 | 1.57 | 1.42 | 1.28 | 1.15 |
| EBITDA(a) | $5,746,000 | $5,029,000 | $4,472,000 | $4,063,000 | $3,549,000 |